Target type: molecularfunction
Catalysis of the phosphorylation of a simple or complex lipid. [GOC:hjd]
Lipid kinase activity refers to the enzymatic catalysis of the transfer of a phosphate group from a donor molecule, such as ATP, to a lipid substrate. This phosphorylation event alters the chemical structure of the lipid, influencing its properties and biological functions. Lipids are essential components of cellular membranes and play crucial roles in signaling pathways, membrane trafficking, and cell growth. Lipid kinases are involved in a wide range of cellular processes, including:
1. **Signal transduction:** Lipid kinases act as key players in signaling cascades by phosphorylating specific lipids, generating second messengers that relay signals from the cell surface to intracellular targets. Examples include the phosphorylation of phosphatidylinositol (PI) by PI kinases, leading to the formation of phosphatidylinositol 4,5-bisphosphate (PIP2), a crucial component of various signaling pathways.
2. **Membrane trafficking:** Lipid kinases regulate membrane dynamics by controlling the composition and properties of cellular membranes. For instance, phosphorylation of phosphatidic acid (PA) by phosphatidic acid kinases (Paks) facilitates the recruitment of proteins involved in vesicle budding and membrane fusion.
3. **Cell growth and differentiation:** Lipid kinases play a critical role in controlling cell growth and differentiation through their involvement in signaling pathways that regulate these processes. For example, phosphatidylinositol 3-kinases (PI3Ks) phosphorylate PI to produce phosphatidylinositol 3,4,5-trisphosphate (PIP3), a key regulator of cell growth and survival.
4. **Immune responses:** Lipid kinases participate in immune responses by modulating the activity of immune cells. For instance, phosphoinositide 3-kinase delta (PI3Kδ) is involved in B cell receptor signaling and plays a role in B cell development and activation.
5. **Metabolic regulation:** Lipid kinases contribute to metabolic regulation by controlling the synthesis and breakdown of lipids. For example, diacylglycerol kinases (DGKs) phosphorylate diacylglycerol (DAG) to produce PA, which is a precursor for the synthesis of other lipids.
The specific lipid substrates and the resulting phosphorylated products are highly diverse, reflecting the wide range of cellular functions regulated by lipid kinase activity. The regulation of lipid kinases themselves is complex and involves a variety of mechanisms, including phosphorylation, protein-protein interactions, and localization to specific cellular compartments. Dysregulation of lipid kinases has been implicated in a variety of diseases, including cancer, inflammation, and metabolic disorders. Therefore, understanding the molecular function of lipid kinase activity is crucial for developing novel therapeutic strategies targeting these diseases.'
"
Protein | Definition | Taxonomy |
---|---|---|
Sphingosine kinase 1 | A sphingosine kinase 1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q9NYA1] | Homo sapiens (human) |
Sphingosine kinase 2 | A sphingosine kinase 2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q9NRA0] | Homo sapiens (human) |
Sphingosine kinase 1 | A sphingosine kinase 1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q9NYA1] | Homo sapiens (human) |
Sphingosine kinase 2 | A sphingosine kinase 2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q9NRA0] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
fingolimod hydrochloride | fingolimod hydrochloride : The hydrochloride salt of 2-amino-2-[2-(4-octylphenyl) ethyl]-1,3-propanediol (fingolimod). Fingolimod Hydrochloride: A sphingosine-derivative and IMMUNOSUPPRESSIVE AGENT that blocks the migration and homing of LYMPHOCYTES to the CENTRAL NERVOUS SYSTEM through its action on SPHINGOSINE 1-PHOSPHATE RECEPTORS. It is used in the treatment of MULTIPLE SCLEROSIS. | hydrochloride | immunosuppressive agent; prodrug; sphingosine-1-phosphate receptor agonist |
4-(4-(4-chloro-phenyl)thiazol-2-ylamino)phenol | substituted aniline | ||
safingol | safingol: RN given refers to the (R-(R*,S*))-isomer | amino alcohol | |
sphingosine | 2-aminooctadec-4-ene-1,3-diol : A 2-aminooctadecene-1,3-diol having its double bond at position 4. sphing-4-enine : A sphingenine in which the C=C double bond is located at the 4-position. sphingenine : A 2-aminooctadecene-1,3-diol having (2S,3R)-configuration. sphingoid : Sphinganine, its homologs and stereoisomers, and the hydroxy and unsaturated derivatives of these compounds. | sphing-4-enine | human metabolite; mouse metabolite |
n,n-dimethylsphingenine | N,N-dimethylsphingosine : A sphingoid that is sphingosine in which the two amino hydrogens are replaced by methyl groups. N,N-dimethylsphingosine: a sphingosine kinase inhibitor | aminodiol; sphingoid; tertiary amino compound | EC 2.7.1.91 (sphingosine kinase) inhibitor; metabolite |
es-285 | 1-deoxysphinganine : A bioactive sphingoid, sphinganine, in which the terminal hydroxy group has been replaced by a hydrogen. spisulosine: from marine organism, Spisula polynyma; structure in first source | amino alcohol; sphingoid | antineoplastic agent |
3-(4-chlorophenyl)-adamantane-1-carboxylic acid (pyridin-4-ylmethyl)amide | organochlorine compound | ||
bml 258 | |||
pf-543 | PF-543: Sphingosine Kinase 1 Selective Inhibitor; structure in first source | sulfonamide | |
rome | (2R)-2-amino-2-(methoxymethyl)-4-(4-octylphenyl)butan-1-ol : A 2-amino-2-(methoxymethyl)-4-(4-octylphenyl)butan-1-ol that has R-configuration. It is a sphingosine kinase-2 inhibitor. Rome: The capital city of Italy. | 2-amino-2-(methoxymethyl)-4-(4-octylphenyl)butan-1-ol | EC 2.7.1.91 (sphingosine kinase) inhibitor |